相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice
Angie C. A. Chiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
TORC1 inhibition enhances immune function and reduces infections in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease
Ai-Ling Lin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging
Brian K. Kennedy et al.
CELL METABOLISM (2016)
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
Axel Montagne et al.
NEURON (2015)
Healthy aging: The ultimate preventative medicine
Matt Kaeberlein et al.
SCIENCE (2015)
The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy
Robert Siman et al.
PLOS ONE (2015)
Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart
Dao-Fu Dai et al.
AGING CELL (2014)
Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet
Olga V. Leontieva et al.
AGING CELL (2014)
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature
Antonella Caccamo et al.
JOURNAL OF NEUROSCIENCE (2014)
Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer's disease
Teng Jiang et al.
PHARMACOLOGICAL RESEARCH (2014)
mTOR inhibition improves immune function in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Late-life rapamycin treatment reverses age-related heart dysfunction
James M. Flynn et al.
AGING CELL (2013)
Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease
Ai-Ling Lin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Rapamycin extends murine lifespan but has limited effects on aging
Frauke Neff et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease
Anson Pierce et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
Sefika Ozcelik et al.
PLOS ONE (2013)
mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome
Simon C. Johnson et al.
SCIENCE (2013)
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Richard A. Miller et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)
Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits
Smita Majumder et al.
PLOS ONE (2011)
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau EFFECTS ON COGNITIVE IMPAIRMENTS
Antonella Caccamo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-beta Levels in a Mouse Model of Alzheimer's Disease
Patricia Spilman et al.
PLOS ONE (2010)
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
David E. Harrison et al.
NATURE (2009)
mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells
Chong Chen et al.
SCIENCE SIGNALING (2009)
Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma
Tim F. Cloughesy et al.
PLOS MEDICINE (2008)
分享论文
